AccuVein Inc., a global leader in medical imaging technology and the creator of the AV300, the world’s first hand-held, non-contact vein illumination device, announced today that the AV300 has been approved for sale in China by the State Food and Drug Administration (SFDA). Hong Kong Fortune Life Trade Limited will be the exclusive distributor of the AccuVein AV300 vein finder in China.
With the addition of China, AccuVein’s AV300 vein illumination device is now available in 88 countries representing two thirds of the world’s population. The AV300 is already being sold in India, Russia, Japan and many other countries. For the full list, please visit accuvein.com/how-to-buy/international/.
“China is a country of 1.3 billion people where emphasis on quality healthcare continues to rise,” said AccuVein CEO Ron Goldman. “We are excited about the opportunity to positively impact patient care and reduce healthcare costs on such a large scale.”
Venipuncture is the most common invasive medical procedure, with millions of procedures conducted every day around the world. Studies show that up to one third of these attempts to access a vein fail the first time, creating unnecessary patient discomfort, as well as additional costs.
The AV300 has been shown to improve peripheral vascular access for IV infusion by projecting a safe pattern of light on a patient’s skin that reveals the position of underlying veins. This can be particularly helpful on patients who have Difficult Venous Access (DVA).
About AccuVein, Inc.
AccuVein (accuvein.com) is a global leader in medical imaging solutions. Its breakthrough product, the AV300, allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving venipuncture and other vascular access procedures.
The AV300 is the world’s only handheld, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies.
AccuVein and the AV300 have received numerous awards and widespread recognition from within the healthcare sector, including the top “gold” prize in the prestigious MDEA design competition as well as the 2011 Frost & Sullivan New Product Innovation Award.
AccuVein’s industry leading and award winning AccuVein AV300 vein illumination solution is in use at more than 750 U.S. hospitals and available for sale in 88 countries.
About Hong Kong Fortune Life Trade Limited
Hong Kong Fortune Life Trade Limited (hkfortunelife.com) specializes in the import and export of innovative, high-end medical devices. Partnering with medical institutions, hospitals, research institutes and business units, they are committed to promoting and popularizing high-technology equipment internationally.
In order to guarantee the quality of the equipment they represent, Hong Kong Fortune Life Trade Limited works with proven, well-known international top- Fortune 500 companies including General Electric Company (GE), 3M of US, Olympus, and Nikon.